Methylergometrine
| Methylergometrine | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Methylergometrine, also known as methylergonovine, is a medication used to prevent or control excessive bleeding following childbirth. It is a uterotonic agent that works by increasing the tone, rate, and amplitude of contractions of the smooth muscle of the uterus.
Pharmacology[edit]
Methylergometrine is a semisynthetic ergot alkaloid derivative. It acts as a partial agonist on serotonin and dopamine receptors, and as an antagonist on alpha-adrenergic receptors. This action results in the contraction of uterine smooth muscle, which helps to reduce postpartum hemorrhage.
Medical uses[edit]
Methylergometrine is primarily used in the management of the third stage of labor and the prevention and treatment of postpartum hemorrhage. It is administered either orally or by injection, depending on the clinical situation.
Side effects[edit]
Common side effects of methylergometrine include nausea, vomiting, hypertension, and headache. In rare cases, it can cause seizures or myocardial infarction.
Contraindications[edit]
Methylergometrine is contraindicated in patients with hypertension, preeclampsia, or eclampsia. It should also be avoided in patients with a history of coronary artery disease or peripheral vascular disease.
Mechanism of action[edit]
Methylergometrine works by stimulating the smooth muscle of the uterus to contract. This is achieved through its action on various receptors, including serotonin receptors and alpha-adrenergic receptors. The increased uterine tone and contractions help to reduce bleeding by compressing the blood vessels in the uterine wall.
Administration[edit]
Methylergometrine can be administered orally, intramuscularly, or intravenously. The route of administration depends on the urgency of the situation and the clinical judgment of the healthcare provider.
Related pages[edit]
-
Methylergometrine
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian